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Community-based prevention leads to an
increase in condom use and a reduction in
sexually transmitted infections (STIs) among men
who have sex with men (MSM) and female sex
workers (FSW): the Frontiers Prevention Project
(FPP) evaluation results
Juan-Pablo Gutierrez1,2*, Sam McPherson3, Ade Fakoya4, Alexander Matheou5, Stefano M Bertozzi1
Abstract
Background: India has an estimated 2.0 million to 3.1 million people living with HIV; it has the highest number of
HIV-positive people in Asia and ranks third in the world. The Frontiers Prevention Project (FPP) was implemented in
2002 to conduct targeted prevention intervention geared towards female sex workers (FSW) and men who have
sex with men (MSM) in the state of Andhra Pradesh (AP). This paper reports the overall changes in behaviour and
STI outcomes between 2003/4 and 2007 and also describes the changes attributed to the FPP.
Methods: The evaluation used two cross-sectional surveys among MSM and FSW at 24 sites in AP. Surveys were
implemented using a similar methodology. Univariate analyses were conducted by comparing means: baseline vs.
four-year follow-up and FPP vs. non-FPP. For both MSM and FSW, random and fixed-effects logit regression models
at the site level were estimated for condom use with last partner, syphilis sero-positivity and HSV 2 sero-positivity. In
addition, for FSW we estimated models for condom use with regular partner, and for MSM we estimated models for
condom use with last female partner.
Results: Among MSM, fixed-effects analysis revealed that FPP was positively correlated with the probability of
condom use with last female sexual partner and negatively correlated with the individual probability of sero-positivity
to syphilis and HSV 2. Among FSW, the FPP intervention was significantly correlated with increased condom use
with regular partners and with lower probability of STI sero-positivity.
Discussion: Important changes in behaviours related to an increase in prevention activities translated to reductions
in STI sero-prevalence in AP, India. In contrast with non-FPP sites, the FPP sites experienced an intense community
approach as part of the FPP intervention, and the general increase in condom use and its effect on STI sero-
prevalence reflected the efficacy of these intense prevention activities focused on key populations in AP.
Background
India has a reported 2.0 to 3.1 million people living with
the human immunodeficiency virus (HIV), representing
the highest number of HIV positive people in Asia and
third in the world. The overall HIV prevalence in India
is 0.36%, a figure below the WHO/UNAIDS threshold
of 1% for generalised epidemic. The high reported HIV
prevalence among some high-risk groups such as female
sex workers (FSW) and men who have sex with men
(MSM) (above 5%), puts the country in the classification
of concentrated epidemic. Protecting India’s large popu-
lation of FSW and MSM from infection is a critical
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priority in its own right, and it is also an effective way to
protect the remaining population from infection, high-
lighting the importance of enduring effective prevention
for these populations [1,2].
Andhra Pradesh (AP), with a total population of 76.2
million, is located in the south-eastern part of India.
This state reported one of the fastest increasing HIV/
AIDS rates in India when the FPP began and is among
the six states in India with the highest prevalence.
About 10% of all AIDS cases in India are in AP. In 2005
the HIV prevalence in ante-natal clinics (ANC) was esti-
mated to be 2%, and the prevalence at sexually trans-
mitted infections (STI) sentinel clinics was 22.8%. The
wide distribution of the epidemic is reflected in the find-
ing that 19 out of 23 districts in AP had a prevalence
exceeding 1%. The sentinel surveillance centre data sug-
gest that the epidemic is not limited to urban areas and
that there is little difference between the prevalence
rates of migrants and non-migrants [3].
The Frontiers Prevention Project (FPP) was implemen-
ted in 2002 by the International HIV/AIDS Alliance to
conduct targeted prevention interventions for key popu-
lations (KP), defined as those at high risk for HIV infec-
tion and transmission, in the state of Andhra Pradesh.
Because of their central role in the Indian epidemic,
FSW and MSM, together with injection drug users
(IDU) and people with HIV (PWH), were defined as KP
for the project. The FPP set out to empower KP by
improving advocacy within these groups, changing poli-
cies that affect these groups, and increasing community
awareness. These efforts, combined with the provision
of a comprehensive package of prevention interventions
implemented on the appropriate scale, aimed to reduce
risk-taking behaviours and STI incidence, thereby result-
ing in a lower HIV incidence among KP, and seconda-
rily among the general population. Additionally, the
targeted populations were involved in program planning,
and dissemination was intended to increase community
ownership of the program and thus its sustainability
after the FPP finished. The prospective external evalua-
tion described here only evaluated impact among MSM
and FSW because of the impossibility of identifying IDU
and PWH at baseline, in advance of project implementa-
tion [4].
The FPP was based on a theory of change (see Figure
1): In countries with concentrated epidemics, well-
defined sets of interventions, focused on key populations
affected by the epidemic, would result in reduced inci-
dence of HIV amongst these populations and would
also result in curbing of the potential spread of the epi-
demic into the broader population. The goal was to
ensure an environment in which prevention was feasible
and adequate services (STI clinics, drop-in centres) and
commodities (condoms, lubricants, STI treatment) for
prevention were available for key populations. Empower-
ment of the KP was believed to improve access by pre-
vention workers to the KP, as well as access to and
utilization of prevention services by the KP. In turn,
risky behaviour and STI prevalence would decrease, and
subsequently, there would be a reduction in HIV inci-
dence among KPs and in the broader community [5-7].
As part of the project, an impact evaluation was
designed to measure the impact of FPP prevention inter-
ventions among FSW and MSM in Andhra Pradesh.
Although the original evaluation underwent major
changes while the program was being implemented, the
final prospective impact evaluation reported dramatic
results and may provide useful lessons for other large-
scale programs seeking to incorporate prospective
impact evaluations into their design.
The original evaluation design was a classic cluster-
randomised trial design with 24 geographically distinct
sites randomised as either FPP sites that would receive
the full FPP prevention program or as non-FPP sites
that would receive no intensive community-based pre-
vention interventions beyond the government’s existing
HIV prevention program. Closely matched sites were
chosen for evaluation within a universe of sites that
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Figure 1 The FPP theory of change.
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were both operationally feasible and where HIV risk
reduction was a priority. Within-pair randomisation was
conducted to determine which site would receive the
intervention and which would serve as comparison.
Extensive community mapping of MSM and FSW at
baseline was included in the evaluation, which was used,
inter alia, to estimate the size of the two populations
[8].
The ultimate goal of the program was to reduce HIV
incidence; however, when the FPP began it was not pos-
sible to include HIV incidence as an endpoint in the
evaluation because of the perception by both the gov-
ernment and the implementing organization that it was
unethical to do so and that it would adversely affect the
prevention program’s acceptability in the community.
As discussed below, those views evolved over the course
of the project. As a result, the original evaluation design
included repeat, cross-sectional, anonymous surveys of
MSM and FSW that collected socio-demographic infor-
mation, limited sexual history, detailed risk behaviour
information about their last three sexual relations, and
samples of blood and urine to test for herpes simples
virus type 2 (HSV 2), syphilis, gonorrhoea and
Chlamydia.
While the baseline survey was being conducted, the
Bill and Melinda Gates Foundation (Foundation) and
the AP State AIDS Control Society (APSACS) decided
to dramatically increase the scale of prevention activities
in the state as part of the Avahan prevention program.
The Avahan program, with the goal of saturating key
populations with prevention interventions, was very
similar in design to the FPP. The most important design
difference between the programs was the degree to
which each individual community participated in deter-
mining which prevention services were of highest prior-
ity for that community; community participation was a
prominent feature for the FPP but not for Avahan.
Because Avahan and APSACS aimed to cover 100% of
AP, the original FPP comparison communities became
Avahan intervention communities very shortly after the
FPP initiated its programs at its intervention sites.
Further complicating the situation, the International
HIV/AIDS Alliance (Alliance) was the implementation
partner for Avahan at many sites in AP [9].
Faced with the loss of the original evaluation design,
the decision was made to proceed with a modified
design that took advantage of (i) the exogenous variabil-
ity resulting from the difference between the FPP and
Avahan programs in the degree of community participa-
tion and (ii) the endogenous variability in program
efforts, spending and coverage across program sites,
reflecting both site-specific differences as well as differ-
ences among the NGOs selected to implement the pre-
vention interventions at the different sites.
The aims of this paper are to describe the socio-
demographic characteristics of the FSW and MSM in
AP as well as to report the results of the estimated
effectiveness of the FPP by using a dosage analysis that
takes advantage of the baseline and follow-up survey
implemented at 24 sites.
Methods
The analysis was a site-level panel analysis that used
repeated cross-sectional surveys of FSW and MSM from
the same geographic sites and followed similar protocols
for identifying hotspots and recruiting participants.
Analyses of the baseline surveys have been widely
published and are not presented here [10,11]. Results
presented here were limited to analyses comparing the
MSM and FSW populations at baseline with the MSM
and FSW populations at the same 24 sites four years
later. Because individual identifiers were not collected,
we designed the analysis as a comparison of two cross-
sectional surveys conducted at the same sites with simi-
lar methodology (i.e., mapping hotspots in each site and
key populations surveyed from those spots). Only the
baseline data from the sites surveyed in the follow-up
were included, and only the HSV 2 and syphilis biologi-
cal endpoints were included.
Sampling
Among the original 24 baseline sites, 62 sub-sites (lim-
ited by the administrative definition of geographic areas
within a district) were described by the type of program
implemented (FPP, Avahan (either implemented by Alli-
ance partners or other CBOs, or neither Avahan nor
FPP) and by the estimated size of the key populations as
reported by the implementing NGOs. Using this dataset
and the constraint that the follow-up surveys could be
implemented at only 24 sub-sites, a subset of 12 FPP
and 12 non-FPP/non-Avahan (referred here after as non
FPP) sub-sites was randomly selected; the selection
probability was proportional to the size of the MSM and
FSW populations at the sites. At these 24 sub-sites, a
follow-up survey was implemented and capillary blood
was collected for HSV 2 and syphilis testing.
Sample size was calculated to detect a difference in
STI prevalence between FPP and non-FPP sites (assum-
ing 12.5% prevalence at non-FPP sites and 9% preva-
lence at FPP sites) with an intra-cluster correlation of
0.05, resulting in 200 individuals per KP per site based
on previous studies [12-14].
Working closely with the community-based organisa-
tions (CBOs) in charge of the implementation, we iden-
tified the survey hotspots for MSM and FSW. The
methodology for this mapping followed the participatory
learning and action tools developed by the IHAA [8,15].
The size of each hotspot was estimated based on the
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individuals present at the time of the visit. To survey
FSW, within each hotspot a subsample was defined
based on a defined sample by sub-site; because of the
smaller number of MSM frequenting the hotspots, all
MSM present at the hotspot were asked to participate
in the survey.
While the mapping intended to be as comprehensive
as possible of each target population, the major limita-
tion when surveying hidden populations is that the sam-
pling universe is restricted to those frequenting
sampling points (hotspots in our case) identified in the
mapping. As the mapping was implemented systemati-
cally and observed by the researchers, there was not an
evident bias in this procedure.
While there is no reason to believe that some types of
hotspots were systematically excluded, there is an expected
sampling bias against MSM and FSW who do not frequent
MSM or SW venues. This expected bias is not of concern
with respect to estimating the impact of the FPP on the
targeted populations because the interventions were also
targeted at the KP who frequent sites, but it does not
reflect the impact on the excluded populations.
To test for potential biases in the population size esti-
mates generated by the CBO’s, an additional mapping
exercise was carried out just before each survey by the
agency in charge of the survey, with estimates compar-
able to the ones provided by the participatory mapping.
Descriptive analysis
Univariate analyses were conducted by comparing sim-
ple means: baseline vs. four-year follow-up and FPP/
Alliance vs. non-FPP sites. This analysis was conducted
to provide a description of the populations at the base-
line and follow-up surveys in terms of their socio-demo-
graphic characteristics as well as the variables defined
below for the impact analysis.
Demographic characteristics reported included age,
whether participants were from the same mandal (the
administrative division below district in AP) as the one
in which they were residing at the time of the interview
(as a measure of migration), literacy rates, and living
arrangements.
For the follow-up, variables related to the intervention
were also examined. The degree of satisfaction with the
prevention activities (support groups and condom
demonstrations) was estimated by asking participants to
rate their satisfaction on a 1-to-10 scale (where 10 was
defined as the best). In addition, we assessed the knowl-
edge of Mythri condoms, a product developed by Alli-
ance India for its activities.
Impact analysis
Multivariate regression analyses took into account dif-
ferences in intervention coverage as measured by
whether the respondent had been exposed to Mythri
condom distribution, had participated in a peer-educa-
tion activity, and/or had visited a community prevention
centre. For these estimations, an intervention variable
was defined by the site category (whether the site was
FPP or non-FPP), and the dosage indicators (coverage)
were included to control for the heterogeneity in imple-
mentation at the FPP sites and the lack of systematically
collected data on prevention activities at the non-FPP
sites.
For both MSM and FSW, random and fixed-effects
logit regression models at the site level were estimated
for condom use with last partner, syphilis sero-positivity
and HSV 2 sero-positivity. For FSW we also estimated
models for condom use with regular partner, and for
MSM we estimated models for condom use with last
female partner.
Random-effects models require additional assumptions
compared to fixed-effects models, but the estimation of
time variant characteristics is more efficient. If the
assumption that errors are not correlated with the inde-
pendent variables (that is needed for the random-effects
models) is not met, then the estimator would be incon-
sistent and the fixed-effects models would be preferred.
As the panel was constructed at the site level, is at this
level where the assumption needs to hold. The Haus-
man test was implemented, but because its results were
not conclusive, both random effects and fixed effects
models were reported [16].
Outcome variables
As mentioned above, the outcome variables were both
behavioural and biomarker-based. Reported condom use
was used as the key behavioural indicator, divided for
FSW between clients and regular partners and for MSM
between male and female partners. In all cases, the vari-
able was defined as 1 when individuals reported using a
condom with each of the defined type of partner and 0
when individuals reported not using a condom for anal
or vaginal penetrative sex during the last intercourse.
Biomarkers used were sero-positivity for syphilis and
sero-positivity for HSV 2. ELISAs were conducted with
the eluted blood from the dried capillary blood spots
collected during the survey using the positivity cut-off
points recommended by the test manufacturers. The
HSV 2 test was the HerpeSelect 2 from Focus Diagnos-
tics, and the syphilis test was the Trepanostik™from
bioMerieux.
While syphilis is a treatable infection and changes in
sero-prevalence are expected to occur due to increased
access to treatment, we included HSV 2 as a variable
because of its use as a marker for HIV risk, as docu-
mented in other studies [17-20]. Assuming that the
population would remain unchanged, there was no
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expectation of change in this indicator, but a reduction
in new infections combined with any population change
would result in a decrease in the overall prevalence of
HSV 2.
Intervention variables
In all models, the FPP effect was estimated as the inter-
action between time (baseline or follow-up) and inter-
vention (FPP or non-FPP). Using this interaction, a time
trend was estimated in addition to a variable that indi-
cated differences between FPP and non-FPP sites as for
the baseline. Note that the FPP vs. Non-FPP comparison
is intended to capture the difference in prevention
approaches that do or do not include extensive commu-
nity participation in the design of the package of inter-
ventions being implemented in the community. The
coverage variables capture the difference in dose of pre-
vention interventions provided in the community.
Control variables
To control for the differential exposure to the interven-
tions as well as for interventions that occurred in the
non-FPP sites, a set of coverage variables was generated
from the collected information. Coverage was defined as
the percentage of the individuals from a given site who
reported participation in key activities for prevention; i.
e., they participated in a condom use demonstration,
were reached by a peer-educator, and visited a drop-off
centre for STI treatment. Because this information was
not available from the baseline questionnaire, for analy-
tical purposes, it was assumed that coverage was identi-
cal in all sites and close to zero. This assumption was
made because prevention activities were described by
the baseline site assessment process as not very exten-
sive. However this assumption affects the interpretation
of the coefficients of these variables, which were there-
fore only useful for determining whether the FPP
approach had a significant & positive incremental
impact; their absolute values are not interpretable.
For MSM, age at the time of the survey, experience in
commercial sex (1 if yes, 0 if no), whether family was
aware of their sexual behaviour (1 if yes, 0 if no), and
ever having sex with a female partner (1 if yes, 0 if no)
were included as control variables. For FSW, additional
control variables were age at the time of the survey, age
at the first commercial intercourse, and whether family
was aware of their commercial sex work (1 if yes, 0 if
no).
Ethical approval
The FPP evaluation was approved by the Ethics Com-
mittees of Mexico’s National Institute of Public Health,
the Administrative Staff College of India, and the Inter-
national HIV/AIDS Alliance. Clearance for the study
was provided by the Indian Health Ministry’s Screening
Committee, Indian Council of Medical Research, New
Delhi.
Results
The intervention was implemented by 14 NGOs at 26
sites in 9 districts across the Rayalseema and Telengana
regions of AP. By April 2007, 8757 FSW, 5597 MSM
and transgender individuals, 4730 PWH and 350 IDU
were registered and were receiving health-related ser-
vices regularly. These services included STI services,
behaviour change communication, condom programs,
community mobilisation, and enabling and structural
interventions. In addition, there was an emphasis on
social capital building, network and support formation,
empowerment, violence reduction, referrals for HIV
testing and basic AIDS care services.
Project-operated STI clinics were set up at all sites,
and the medical officers were trained in syndromic case
management and basic AIDS care. By April 2007, 6328
FSW, 3136 MSM and 2363 PWH had been given STI
treatment; in addition, 3161 FSW, 2086 MSM and 481
PWH received treatment for asymptomatic gonococcus
and/or Chlamydia infections. Outreach was performed
through a team of outreach workers and peer educators
(selected from the community). Condoms were distribu-
ted to the KP through the outreach team as well as
from the clinic. In total, 3.8 million free condoms were
distributed, and 600,000 were distributed through social
marketing. Support groups were formed, especially in
the Karimangar and Khammam districts, amongst PWH.
A state-level sex-worker network was formed.
Overall, 2,786 MSM were interviewed at the 24 sub-
sites at baseline: 1,680 at the FPP sub-sites and 1,106 at
the non-FPP sub-sites. During the follow-up survey, the
team was able to identify a much smaller number of
MSM at the non-FPP sub-sites. Only 218 MSM were
interviewed at the non-FPP sub-sites and 1,317 MSM at
the FPP sites (total sample size in the follow-up was
1,535). At the same sites at baseline, 3,442 FSW were
interviewed: 1,692 in FPP and 1,750 in non-FPP sites.
During the follow-up survey, 1,292 FSW were inter-
viewed at the FPP sites and 855 at the non-FPP sites.
Table 1 and Table 2 describe sample characteristics in
both surveys (baseline and follow-up) of MSM and
FSW, respectively. Basic demographic characteristics
were similar between individuals in both surveys. For
the analysis, we included only individuals in the follow-
up survey who were likely to have been at the sites at
baseline, i.e., people who reported living or working in
the area for at least four years.
Table 1 also compares the outcome variables between
baseline and follow-up for MSM. Note that the percen-
tage of MSM who reported condom use with last
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partner increased for both non-FPP and FPP sites
between baseline and follow-up (from 77% and 79% to
90% and 94%, respectively), and the percentage of MSM
who reported condom use with last female partner also
increased but remained low at non-FPP and FPP sites
between baseline and follow-up (from 14% and 15% to
32% and 40%, respectively). There was an impressive
decrease of syphilis sero-prevalence between baseline
and follow-up in both non-FPP and FPP sites (from 20%
and 22% to 9% and 12%, respectively); similar trends
were seen for HSV 2 sero-prevalence (from 34% and
40% to 29% and 32%, respectively).
We compared the outcome variables between baseline
and follow-up for FSW in Table 2. Condom use with
Table 1 Characteristics of MSM participants in the survey by type of intervention and time (average and 95% CI)
Characteristics Pre-intervention survey Post-intervention survey
NFPP Mean FPP Mean NFPP Mean FPP Mean
Age 27.71
(20.10-29.32)
28.57
(27.95 -29.19)
31.45 (+)
(29.14-33.76)
29.14
(27.76-30.52)
Participants from the same village where they were interviewed 90%
(85% -95%)
96%
(94%-0.98%)
92%
(86% -98%)
95%
(93% -98%)
Participants from the same mandal in which they were interviewed 82%
(68% -96%)
89%
(77%-100%)
96%
(85%-100%)
90%
(77%-100%)
Participants who were currently in a relationship with another man 90%
(98%-100%)
100%
(99-100%)
100% 99%
(99-100%)
Participants currently living with a male partner 5%
(1% -9%)
6%
(3%-10%)
7%
(2%-15%)
17% (+)
(8%- 26%)
Participants married to a male 5%
(3% -7%)
5%
(2% -8%)
10%
(2% -17%)
16%(+)
(9%-22%)
Participants whose families were aware of their sexual preferences 35%
(25% -44%)
48% (*)
(40% -56%)
75%(+)
(58% -93%)
17%(+)
(8%-26%)
Participants who used lubricants 46%
(42% -51%)
53%
(40% -66%)
30% (+)
(26% -33%)
33%(+)
(22%-44%)
Participants who reported participation in commercial sex 19%
(10%-28%)
22%
(17%-27%)
51%(+)
(33% -68%)
42%(+)
(36%-48%)
Participants who reported that at least one of the 3 last sexual intercourses was
commercial
13%
(7% -19%)
19%
(14% -25%)
44%(+)
(27% -60%)
39%(+)
(35%-44%)
Participants who used a condom during their last sexual encounter 77%
(54%-100%)
79%
(50%-100%)
90%
(80% -99%)
94%
(92% -96%)
Participants who have had a sexual relation with a female 73%
(66% -80%)
72%
(66% -79%)
86%(+)
(76% -97%)
83%
(72% -93%)
Participants who used a condom with their last female partner 14%
(9% -18%)
15%
(7% -23%)
32%(+)
(30% -34%)
40%(+)
(32% -49%)
Participants who were sero-positive for syphilis 20%
(10% -30%)
22%
(14% -30%)
9%
(3% -16%)
12%(+)
(5% -19%)
Participants who were sero-positive for HSV 2 34%
(19% -49%)
40%
(32% -47%)
29%
(16% -43%)
32%
(27% -37%)
Participants who received treatment for their last STI episode 80%
(75% -84%)
98% (*)
(95%-100%)
100%(+) 100%(+)
Participants who had an HIV test 12%
(7% -17%)
9%
(4% -14%)
52% (+)
(42% -62%)
54% (+)
(50% -59%)
Number of male partners in the last 4 weeks 3.72
(3.11-4.33)
5.75 (*)
(3.97-3.53)
6.83 (+)
5.62-8.05)
7.51
(6.08- 8.95)
Participants who had attended a condom demonstration 62%
(53% -71%)
66%
(59% -73%)
Average rate of condom demonstration attendance 7.86
(7.69-8.03)
8.50 (*)
(8.04-8.96)
Participants who had been contacted by a peer educator 53%
(36%-70%)
52%
(36%-68%)
Participants who had visited a drop-in centre 42%
(13%-72%)
54%
(40%-68%)
* p < 0.05 FPP vs NFPP; + p < 0.05 baseline vs. follow-up
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last client increased for non-FPP and FPP sites between
baseline and follow-up from 68% and 72% to 98% and
99%, respectively. While condom use with regular part-
ners also increased for non-FPP and FPP sites between
baseline and follow-up (from 5% and 7% to 21% and
38%, respectively), unprotected sex with these partners
remained high. As among MSM, biomarkers from FSW
also showed an impressive reduction, with syphilis sero-
prevalence dropping in both non-FPP and FPP sites
from 13% and 18% at baseline to 8% and 10% at follow-
up; HSV 2 sero-prevalence decreased at the FPP sites
from 46% at baseline to 33% at follow-up but increased
in the non-FPP sites from 47% at baseline to 49% at fol-
low-up. With regard to prevention activities, an impor-
tant increase in FSW participation in support groups
occurred for both FPP and non-FPP sites (from 10% at
baseline to 76% at follow-up and from 13% at baseline
to 66% at follow-up, respectively).
Table 2 Characteristics of FSW participants in the survey by type of intervention and time (average and 95%CI)
Characteristics Pre-intervention survey Post-intervention survey
NFPP FPP NFPP FPP
Age 27.82
(27.29- 28.35)
27.61
(26.92 -28.30)
29.67(+)
(28.87-30.48)
29.92(+)
(29.09-30.76)
Participants from the same village where interviewed 90%
(83% -97%)
96%
(92% -99%)
100%(+)
(99%-100%)
100%(+)
(99%-100%)
Participants from the same mandal where interviewed 83%
(73% -94%)
60%
(34% -85%)
98% (+)
(97% -98%)
100% (+.*)
Participants who are married 10%
(7% -13%)
18%
(8% -29%)
4% (+)
(1% -6%)
13%
(2%-27%)
Participants who have participated in a support group 13%
(3% -23%)
10%
(1% -19%)
66%(+)
(45% -88%)
76%(+)
(65%-87%)
Participants whose families are aware of their sexual work 33%
(24%-42%)
30%
(19%-41%)
45%
(32%-58%)
49% (+)
(33%-65%)
Participants who used a condom with their last client 68%
(55% -80%)
72%
(62% -82%)
98% (+)
(97%-100%)
99% (+)
(98%- 100%)
Participants who have a regular partner 56%
(50% -63%)
59%
(48% -70%)
90%(+)
(82% -97%)
83%+
(74% -92%)
Participants who used a condom with their regular partner 5%
(2% -8%)
7%
(4% -10%)
21%(+)
(14% -28%)
38% (+)
(16% -60%)
Participants who received treatment for their last STI episode 90%
(86% -95%)
84%
(78% -90%)
94%
(91% -97%)
95% (+)
(92% -98%)
Participants who have had an HIV test 7%
(4% -11%)
13%
(8% -19%)
87%(+)
(82% -92%)
90%(+)
(85% -96%)
Participants who are sero-positive to syphilis 13%
(7% -19%)
18%
(11% -25%)
8%(+)
(4% -11%)
10%(+)
(9% -12%)
Participants who are sero-positive to HSV 2 46%
(25% -66%)
47%
(32% -62%)
21%
(13% -29%)
29%(+)
(14% -44%)
Average age of first commercial intercourse 23.76
(23.32 -23.32)
23.13
(22.13-22.13)
23.92
(23.12-23.12)
23.32
(21.82-21.82)
Average age of first sexual intercourse 15
(14.87-15.13)
15.30
(14.89-15.71)
16.54(+)
(16.28-16.80)
16.41
(15.38-17.44)
Participants who have participated in a condom demonstration 74%
(59%-90%)
88%
(75%- 100%)
Participants who know about Mytrthi condoms 10%
(10% -18%)
9%
(3% -15%)
Average satisfaction with support groups 7.56
(6.77-8.35)
8.27
(7.75-8.79)
Average rate of condom demonstrations 7.37
(6.63- 8.12)
8.45(*)
(7.85- 9.05)
Average number of clients in the last week 9.90
(6.72-13.09)
9.12
(6.32-11.92)
Participants who have visited a drop-in centre 30%
(11% -49%)
68%(*)
(54% -81%)
* p < 0.05 FPP vs NFPP; + p < 0.05 baseline vs follow-up
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Dosage was highly heterogeneous across sites, ranging
from none to 90% for the average measure (simple
mean of the 3 indicators). Figure 2 shows the distribu-
tion of the 3 dosage measures as estimated from the
surveys of both MSM and FSW at the site level. Figure
3 shows that because of other prevention efforts imple-
mented in the non-FPP sites, the average coverage of
the 3 dosage indicators was similar between FPP and
non-FPP sites. While dosage tended to be higher among
FPP sites, some FPP sites had low intervention levels (at
least according to the dosage indicators used) and some
non-FPP sites had higher levels of prevention activities.
Overall, the highest exposures were for condom distri-
bution activities, followed by peer contact. Utilization of
drop-in centres was lower and possibly related to STI
symptoms. These data were used to estimate the effect
of prevention activities on the outcome indicators,
assuming a direct relationship between intervention
intensity and results.
Regression analyses were conducted, adjusting all
models for sampling design (using random and fixed-
effects models by site). The logistic model results are
0
.2
.4
.6
.8
1
FSW
condom_exposure peer_exposure
center_exposure
0
.2
.4
.6
.8
1
MSM
condom_exposure peer_exposure
center_exposure
Figure 2 Dosage measures distributed across sites (histogram). Bottom: The x-axis represents sites and the y-axis represents percentages.
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reported for MSM in Table 3 and for FSW in Table 4.
In both cases, all models were also adjusted for age and
dosage measures. The outcome variable was the interac-
tion between time and intervention (FPP).
The analysis for MSM included as covariates whether
the participant reported participating in commercial sex
during the three most recent intercourses and whether he
had had a female sexual partner. As presented in Table 4,
there were significant and positive effects of the FPP
compared to the non-FPP interventions for condom use
with female partners and for syphilis and HSV 2 sero-posi-
tivity. The impact variable (interaction between time and
intervention) in the fixed-effects model was positively cor-
related with the probability of condom use with last female
sexual partner and negatively correlated with the indivi-
dual probability of syphilis sero-positivity and HSV 2 sero-
positivity. Age was negatively associated with condom use
with regular partners and positively associated with both
0
.1
.2
.3
.4
NFPP FPP
FSW
condom_exposure peer_exposure
center_exposure
0
.1
.2
.3
NFPP FPP
MSM
condom_exposure peer_exposure
center_exposure
Figure 3 Dosage measures by intervention (FPP vs. non-FPP sites) (histogram). Bottom: The y-axis represents the average site percentages
for each dosage measure.
Table 3 Effect of FPP on selected outcome variables for MSM in AP, India*
Used condom with
last male sexual
partner
Used condom with
last female sexual
partner
Sero-positivity for
HSV 2
Sero-positivity for
syphilis
Random
effects
Fixed
effects
Random
effects
Fixed
effects
Random
effects
Fixed
effects
Random
effects
Fixed
effects
FPP = 1 -0.138 0.037 0.658 0.484
Follow-up = 1 1.029 0.908 2.087** 2.268** -2.154** -2.012* -4.092*** -3.798**
FPP * Follow-up 0.246 0.302 0.605 1.196** -1.368** -1.482*** -0.748** -0.687**
Site average exposure to condom
demonstrations
2.778 2.758 -2.321* -3.481** 4.024** 4.083** 4.912** 4.445**
Site average exposure to peer educators 0.006 0.040 3.052* 4.823** -1.425 -0.365 -0.684 0.423
Site average access to drop-in centres -0.636 -0.494 -1.049 -1.966 0.094 -1.125 0.756 -0.461
Age in years -0.047 -0.047*** -0.134*** -0.134*** 0.029*** 0.030*** 0.059*** 0.058
At least 1 of 3 last sexual encounters was
commercial = 1
0.114 0.121 -0.4121** -0.370** 4.63e-06 -0.011 -0.113 -0.118
Had a female sexual partner = 1 0.360 0.379** -0.166 -0.182 -0.4371*** -0.444***
Constant 1.272 1.799*** -2.722*** -2.261***
N 2 361 2 361 1 510 1 510 2 624 2 624 2 579 2 579
*** p < 0.001, ** p < 0.05, * p < 0.1. All values from the regressions are the coefficients.
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syphilis and HSV 2 sero-positivity. We found a significant
and positive difference between baseline and follow-up for
condom use with a female partner and a negative differ-
ence between baseline and follow-up for syphilis and HSV
2 sero-positivity. For the dosage measures, access to con-
doms paradoxically seemed to have a reverse effect: it was
negatively correlated with condom use and positively cor-
related with STIs. Participation in commercial sex was
correlated with lower probability of condom use with
female partners. Having had sex with female partners was
correlated with a higher probability of condom use with
last male partner and lower probability of syphilis sero-
positivity.
Table 4 reports the results for FSW. The FPP interven-
tion had a significant effect on condom use with regular
partners and on STI sero-positivity. The effect variable
was positively correlated with condom use with regular
partners in both random and fixed-effects models and
negatively correlated with the probability of syphilis and
HSV 2 sero-positivity. The trend variable (time) sug-
gested a general increase in condom use with both clients
and regular partners as well as a drop in STI sero-preva-
lence. Age was negatively correlated with condom use
with last client and with a decline in use for older FSW
but not with condom use with regular partners. Age was
also positively correlated with STI sero-status. Access to
condom demonstrations was both positively correlated
with condom use and negatively correlated with STIs.
Access to peer-education and to drop-off centres was
correlated with a higher probability of STIs.
Discussion
The results presented here highlight some important
overall changes in sexual behaviours among MSM and
FSW in AP, India, comparing 2 cross-sectional surveys
implemented in the same sub-sites with 3 years differ-
ence; these changes were associated with changes in STI
sero-prevalence: FPP sites over time had increased
reductions of STIs among MSM & FSW as compared to
non-FPP. The reported trends suggest that important
prevention efforts established and implemented in AP
effectively modified the risk of STIs, including HIV,
among the population vulnerable to the HIV epidemic;
the results also suggest that if the proposed theory of
change is correct, the prevention efforts also reduced
the risk of HIV infection among the general population.
Moreover, these results are consistent with those
reported for Karnataka (a state bordering AP), where
increased safe sexual behaviours were found to be asso-
ciated with a reduction in STIs [21].
In addition to the overall changes, important differ-
ences were noted between the FPP and non-FPP sites.
These differences may be attributed to the intensive
community approach of the FPP intervention.
These positive results, even considering the limitations
of the evaluation design, suggest that a strong commu-
nity component may significantly potentiate prevention
impact. It is all the more convincing because over time
Avahan became increasingly focused on community
mobilization. While this supports the arguments in
favour of community participation, it also calls for more
robust evaluation in the future to characterize and
quantify the benefits and costs of different approaches
for community engagement and mobilization to accom-
pany the provision of prevention services.
There were, however, areas that still require additional
attention, areas in which the impact on condom usage
was less evident. First, with regard to the female
Table 4 Effect of FPP on selected outcome variables for FSW in AP, India
Used condom with last
sexual client
Used condom with last
sexual regular partner
Sero-positivity for HSV
2
Sero-positivity for
syphilis
Random
effects
Fixed
effects
Random
effects
Fixed
effects
Random
effects
Fixed
effects
Random
effects
Fixed
effects
FPP = 1 0.135 -0.187 0.737** 0.673
Follow-up = 1 2.519** 2.212** 1.774** 2.079* -1.725** -2.248*** -2.324*** -2.450***
FPP * Follow-up 0.569 0.554 1.091** 1.104** -0.490* -0.623** -0.894*** -0.948***
Site average exposure to condom
demonstrations
-1.304 4.826 3.011 7.551** -1.708 -1.150 -7.350*** -7.560***
Site average exposure to peer
educators
-1.304 -2.287 -3.247 -8.088** 1.955 1.891 6.548*** 6.871***
Site average access to drop-in centres -2.002** -1.863** -0.231 -0.112 1.745** 2.077*** 3.814*** 3.932***
Age in years -0.029* -0.032* 0.024 0.023 0.038** 0.035** 0.025** 0.024**
Age of first commercial sex -0.028 -0.022 -0.021 -0.023 -0.049** -0.044** -0.008 -0.007
Constant 2.348*** -3.097*** -2.019*** -0.880**
N 3 329 3 084 2 091 2 091 3 603 3 579 3 516 3 516
*** p < 0.001, ** p < 0.05, * p < 0.1. All values from the regressions are the coefficients
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partners of MSM, the reasons for low condom usage
varied but one of the primary reasons cited in the quali-
tative analyses was that many MSM did not disclose
their sexual orientation to their wives and therefore
struggled to explain the necessity of condom usage. This
issue may be particularly difficult to address in places
like AP where sterilisation is such a common form of
contraception. Therefore, prevention work is handi-
capped unless it addresses broader issues surrounding
sexual identity, stigma and discrimination [2,22]. As
reported in other studies, these data reflect the need for
prevention activities that address the cultural needs spe-
cific to MSM in India [23,24].
Similarly, low condom use by FSW with regular or
non-paying partners is a serious concern. Their relation-
ships with these partners are likely to have emotional
(trust) and/or economic (security, protection, coercion)
characteristics that interfere with regular condom use.
While these areas highlight room for improvement,
some increases in condom usage with wives and regular
partners and the almost universal condom use with cli-
ents by FSW and with male partners by MSM suggest
that prevention activities have had a strongly positive
effect over the period of observation.
There are, however, some caveats. First, the desired
behaviour change was clear to all participants, and more
so after three years of prevention promotion in their
communities; therefore, the self-reports of condom usage
should be treated with caution. Second, the complica-
tions of the evaluation design, most specifically the intro-
duction and expansion of the Avahan project, made it
difficult to estimate the effects of the FPP because we
were not able to differentiate the changes observed in the
study from secular trends [9]. In addition, there were
important differences in the size of the sample by type of
site in the pre and post intervention surveys for MSM.
During the post-intervention survey, a much smaller
fraction of the expected MSM in the non FPP sites was
interviewed. We don’t have sufficient data to explain the
cause of this significant difference in response rates. It
could have to do with the degree to which the FPP
NGOs facilitated access to the hotspots in the follow-up
survey; it could have to do with some concerns that the
MSM population had about participating at the time of
the survey, concerns that were less acute in the FPP sites.
It is speculative to suggest what direction the smaller
sample might bias the outcome measures. If the smaller
sample has a higher proportion of the most visible, most
at-risk MSM then it could exaggerate the estimated
impact. If the same factors that lead the population to be
less accessible to the survey are associated with under-
reporting of risk, or with reduction of high-risk venues,
then the impact might be underestimated.
Conclusions
The FPP-specific results here strongly suggest that there
are important benefits associated with approaches that
engage communities in the design and implementation
of prevention interventions for their communities. The
overall results (the time trends) documents important
changes in sexual behaviours and reductions in STI pre-
valences that accompany the scale-up of community-
wide prevention programs that achieve high levels of
coverage. These changes are also accompanied by
important reductions in HIV prevalence during the
same period that has been documented elsewhere.
These results should motivate others to both imple-
ment similar comprehensive prevention programs as
well as include more robust prospective evaluations in
the programs so that the problems of attribution illu-
strated here can be minimized. It is also important to
better evaluate the potential additional effect of the par-
ticipatory approach, as part of the scale up of prevention
programs in the future.
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